THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 135 filers reported holding THERAPEUTICSMD INC in Q4 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $28,000 | -9.7% | 72,757 | -16.7% | 0.00% | – |
| Q4 2021 | $31,000 | -76.9% | 87,357 | -51.6% | 0.00% | – |
| Q3 2021 | $134,000 | -77.8% | 180,521 | -64.4% | 0.00% | -100.0% |
| Q2 2021 | $604,000 | -14.1% | 507,289 | -3.3% | 0.00% | 0.0% |
| Q1 2021 | $703,000 | +12.8% | 524,865 | +1.9% | 0.00% | 0.0% |
| Q4 2020 | $623,000 | -26.9% | 515,020 | -4.5% | 0.00% | 0.0% |
| Q3 2020 | $852,000 | +23.5% | 539,306 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $690,000 | +17.9% | 551,662 | -0.0% | 0.00% | 0.0% |
| Q1 2020 | $585,000 | -47.4% | 551,726 | +20.1% | 0.00% | 0.0% |
| Q4 2019 | $1,112,000 | -53.5% | 459,578 | -30.2% | 0.00% | -66.7% |
| Q3 2019 | $2,390,000 | +37.4% | 658,439 | -1.5% | 0.00% | 0.0% |
| Q2 2019 | $1,739,000 | -51.1% | 668,793 | -8.4% | 0.00% | -40.0% |
| Q1 2019 | $3,557,000 | +33.8% | 730,468 | +4.7% | 0.01% | 0.0% |
| Q4 2018 | $2,659,000 | -46.7% | 697,850 | -14.8% | 0.01% | -37.5% |
| Q3 2018 | $4,989,000 | +11.1% | 819,080 | +13.8% | 0.01% | 0.0% |
| Q2 2018 | $4,490,000 | +66.3% | 719,568 | +26.6% | 0.01% | +60.0% |
| Q1 2018 | $2,700,000 | -15.0% | 568,233 | -5.1% | 0.01% | -16.7% |
| Q4 2017 | $3,178,000 | +54.2% | 598,561 | +53.6% | 0.01% | +50.0% |
| Q3 2017 | $2,061,000 | +7.5% | 389,563 | +7.0% | 0.00% | 0.0% |
| Q2 2017 | $1,918,000 | -5.9% | 363,914 | +28.5% | 0.00% | -20.0% |
| Q1 2017 | $2,039,000 | +40.9% | 283,141 | +12.9% | 0.01% | +25.0% |
| Q4 2016 | $1,447,000 | -18.6% | 250,734 | -3.9% | 0.00% | -20.0% |
| Q3 2016 | $1,777,000 | +15.4% | 260,926 | +44.0% | 0.01% | 0.0% |
| Q2 2016 | $1,540,000 | +770.1% | 181,175 | +556.4% | 0.01% | +400.0% |
| Q1 2016 | $177,000 | -33.2% | 27,600 | +7.8% | 0.00% | 0.0% |
| Q4 2015 | $265,000 | -11.1% | 25,600 | -32.5% | 0.00% | 0.0% |
| Q2 2015 | $298,000 | +38.0% | 37,913 | +6.0% | 0.00% | 0.0% |
| Q1 2015 | $216,000 | – | 35,761 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,460,225 | $24,914,000 | 4.95% |
| Newtyn Management, LLC | 1,800,000 | $12,960,000 | 1.95% |
| 1492 Capital Management LLC | 222,485 | $1,602,000 | 1.25% |
| SANDERS MORRIS HARRIS LLC | 967,200 | $6,964,000 | 1.18% |
| MORGENS WATERFALL VINTIADIS & CO INC | 180,000 | $1,296,000 | 1.15% |
| SPHERA FUNDS MANAGEMENT LTD. | 580,000 | $4,176,000 | 0.82% |
| Rock Springs Capital Management LP | 1,600,000 | $11,520,000 | 0.66% |
| STONERIDGE INVESTMENT PARTNERS LLC | 467,425 | $3,365,000 | 0.45% |
| Capital Impact Advisors, LLC | 157,411 | $1,133,000 | 0.45% |
| GILDER GAGNON HOWE & CO LLC | 3,059,690 | $22,030,000 | 0.37% |